The purpose of the study is to characterize baseline multidisciplinary tumor board (MDTB) context and variability, evaluate the relationship between baseline fitness of patients with cancer and initial treatment recommendations, and assess the impact of the INSPIRE intervention, which involves including electronic patient reported outcomes (ePROs) within MDTB on MDTB discussion content, provider burden, treatment recommended and received, healthcare utilization, and patient-reported outcomes.
None
aged 18 years or older;
with suspected or confirmed diagnosis of pancreatic, breast, and gynecologic cancer (all stages) within 8 weeks of diagnosis;
intention to be treated at a participating institution;
with verbal fluency in English or Spanish; and
University of Alabama at Birmingham
Lead sponsor
University of Oklahoma
Collaborator
University of California, Los Angeles
Collaborator
Canopy Cancer Collective, LLC
Collaborator